HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 27 March 2013

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  26 papers were listed this time. Here's a few in our areas of research interest:

Mavranezouli I, Meader N, Cape J, et al. The Cost Effectiveness of Pharmacological Treatments for Generalized Anxiety Disorder. Pharmacoeconomics. 2013 Mar 20. [Epub ahead of print] PubMed PMID: 23512146.

Skedgel C, Rayson D, Younis T. Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer? Ann Oncol. 2013 Mar 19. [Epub ahead of print] PubMed PMID: 23510987.

Faria R, McKenna C, Wade R, et al. The EOS 2D/3D X-ray imaging system: A cost-effectiveness analysis quantifying the health benefits from reduced radiation exposure. Eur J Radiol. 2013 Mar 7. [Epub ahead of print] PubMed PMID: 23473735.